- Remove All
- Your shopping cart is currently empty
Protoporphyrin IX disodium, as a radiation sensitizer, enhances the production of ROS and induces DNA damage even under hypoxic conditions. It also acts as a photosensitizer, undergoing direct degradation through photobleaching upon light exposure. This compound accumulates in rat tumor cells following administration of 5-aminolevulinic acid (5-ALA). When activated with a peak wavelength of 405 nm, Protoporphyrin IX disodium selectively improves basal cell carcinoma. It shows promise in pharmacological research of sonodynamic and photodynamic therapy for cancers such as bladder cancer and nodular basal cell carcinoma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Protoporphyrin IX disodium, as a radiation sensitizer, enhances the production of ROS and induces DNA damage even under hypoxic conditions. It also acts as a photosensitizer, undergoing direct degradation through photobleaching upon light exposure. This compound accumulates in rat tumor cells following administration of 5-aminolevulinic acid (5-ALA). When activated with a peak wavelength of 405 nm, Protoporphyrin IX disodium selectively improves basal cell carcinoma. It shows promise in pharmacological research of sonodynamic and photodynamic therapy for cancers such as bladder cancer and nodular basal cell carcinoma. |
In vitro | Protoporphyrin IX disodium, when administered at a dosage of 3.6 nmol/g to tissue, causes necrosis of the normal rat colonic mucosa upon exposure to light. At a concentration of 6.6 nmol/g in rat tumors, it delays tumor growth following irradiation. Additionally, a rapid increase in nuclear G4 levels in Hela cells is observed with Protoporphyrin IX disodium at concentrations ranging from 0 to 25 μM, when applied for 2 hours. |
In vivo | Following a single intravenous injection of aminolevulinic acid at a dosage of 300 mg/kg, the highest concentrations of Protoporphyrin IX disodium were observed in the liver and intestines of rats, approximately 3 hours post-administration, reaching about 6.3 nmol/g of tissue. This was followed by the aorta, which showed a concentration of 4.3 nmol/g of tissue, and the esophagus, which had around 2.1 nmol/g of tissue. |
Molecular Weight | 606.62 |
Formula | C34H32N4Na2O4 |
Cas No. | 50865-01-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.